NCT06882577 Heart Evaluation of Acute Ischemic Stroke With Reperfusion Therapy
| NCT ID | NCT06882577 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Soochow University |
| Condition | Acute Ischemic Stroke |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2025-03-31 |
| Primary Completion | 2026-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2025-03-31 with a primary completion date of 2026-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Heart Evaluation of Acute ischemic stroke with Reperfusion Therapy (HEART) is a single-center observational registry evaluating the heart of patients hospitalized for acute ischemic stroke with reperfusion therapy. This registry aims to establish quantified risk stratification and prognostic models, as well as suggest effective diagnostic and therapeutic strategies.
Eligibility Criteria
Inclusion Criteria: 1. Written informed consent by patient 2. Age ≥ 18 years 3. Acute ischemic stroke (with matching brain lesion on MR imaging) 4. Enrolment within 24 h after onset of stroke-related symptoms. Exclusion Criteria: 1. Pregnancy and / or breast-feeding. 2. Participation in an interventional study. 3. Patients refuse to participate in the research.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06882577 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Ischemic Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06882577 currently recruiting?
Yes, NCT06882577 is actively recruiting participants. Contact the research team at buildingdoc@163.com for enrollment information.
Where is the NCT06882577 trial being conducted?
This trial is being conducted at Suzhou, China.
Who is sponsoring the NCT06882577 clinical trial?
NCT06882577 is sponsored by Soochow University. The trial plans to enroll 400 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.